COS activated AMPK in two human colorectal adenocarcinoma cell lines, HT-29 and Caco-2, and inhibited NF-κB transcriptional activity and NF-κB-mediated inflammatory response. Here, NFKB1 is linked to colorectal adenocarcinoma.